OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...
Persistent contacts between Climp63 and microtubules cause mitotic defects and nuclear fragmentation
This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...
News-Medical.Net on MSN
Experimental RNA drug shows promise for repairing DNA and healing tissue damage
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback